BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30
• 31

• Drug Development

  Janssen Biotech Inc. Release: IMBRUVICA (Ibrutinib) Phase 3 RAY Data Show Significant Improvements In Progression-Free Survival Versus Temsirolimus In Patients With Relapsed Or Refractory Mantle Cell Lymphoma

  December 7, 2015

   · 

  13 min read
• Drug Development

  Janssen Research & Development Release: Ibrutinib (IMBRUVICA) Significantly Improved Progression-Free And Overall Survival Versus Chlorambucil In Patients With Treatment-Naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  December 7, 2015

   · 

  14 min read
• Veloxis Pharmaceuticals A/S Launches EnvarsusXR For Treatment Of Kidney Transplant Patients In U.S.

  December 7, 2015

   · 

  4 min read
• United Laboratories Inc. And Debiopharm Announce The Launch Of Pamorelin LA In The Philippines

  December 7, 2015

   · 

  3 min read
• Drug Development

  Aclaris Initiates Phase II Clinical Trial Of A-101 For Treatment Of Common Warts

  December 7, 2015

   · 

  3 min read
• Drug Development

  SteadyMed Demonstrates Potential For Reduced Infusion Site Sensitivity Associated With Trevyent Compared To Remodulin

  December 7, 2015

   · 

  3 min read
• Drug Development

  Zogenix Announces New Efficacy And Safety Data On ZX008 For Treatment Of Seizures In Dravet Syndrome

  December 7, 2015

   · 

  6 min read
• Drug Development

  Curis, Inc. Reports Clinical Activity Of CUDC-907 In Patients With DLBCL Harboring MYC Oncogene Alterations At The 2015 American Society of Hematology Annual Meeting

  December 7, 2015

   · 

  10 min read
• Biotech Bay

  Sangamo BioSciences Presents Data At The 2015 American Society of Hematology Meeting Highlighting ZFP Therapeutic Programs For Hemophilia And Hemoglobinopathies

  December 7, 2015

   · 

  9 min read
• Drug Development

  Biscayne Pharmaceuticals Presents Data At 2015 American Epilepsy Society Meeting Confirming BIS-001 Is A Novel Mechanism, Highly Potent And Well-Tolerated Anti-Epileptic Drug

  December 7, 2015

   · 

  4 min read